| High Definition Medicine for Solid Tumors Oncology (NCT06590506) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2023-03-02 |
| ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism (NCT02806817) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-07-01 |
| PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. (NCT02922218) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-06-01 |
| Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer (NCT02802098) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-05-01 |
| PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. (NCT02925702) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-02-01 |
| Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics (NCT02619162) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2015-07-01 |
| PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. (NCT02787837) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2014-05-01 |
| PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. (NCT02362620) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2014-05-01 |
| SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone (NCT02928432) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2013-06-01 |
| Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) (NCT03075735) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2013-01-15 |
| Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic (NCT01703910) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2012-11-01 |
| Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors (NCT01548924) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2012-04-01 |
| Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates (NCT01484080) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2011-10-01 |
| Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets (NCT01454180) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2011-10-01 |